Ternák Gábor, Berényi Károly, Sümegi András, Szenczi Ágnes, Fodor Barbara, Németh Balázs, Kiss István
Institute of Migration Health, Medical School, University of Pécs, Szigeti st. 12., H-7624 Pécs, Hungary.
Department of Public Health Medicine, University of Pécs, Szigeti st. 12., H-7624 Pécs, Hungary.
Antibiotics (Basel). 2020 Sep 25;9(10):643. doi: 10.3390/antibiotics9100643.
The possible role of the altered intestinal microbiome in the development of malignancies has been raised recently in several publications. Among external factors, antibiotics are considered to be the most important agent capable of producing dysbiosis in the gut flora, either temporally or permanently. The human microbiome has several beneficial effects in terms of maintaining appropriate human health, but its alteration has been implicated in the development of many illnesses. Our basic aim was to explore a possible relationship between the consumption of different antibiotic classes and the incidence of the most common cancer types (male, female) in European countries. A database of the average, yearly antibiotic consumption (1997-2018) has been developed and the consumption figures were compared to the eight, most frequent cancer incidence calculated for 2018 in 30 European countries. Pearson correlation has indicated different degrees of positive (supportive) and negative (inhibitor) significant associations between antibiotic consumption figures and cancer prevalence. It has been observed that certain antibiotic classes with positive correlation probably augment the incidence of certain cancer types, while others, with negative correlation, may show some inhibitory effect. The relatively higher or lower consumption pattern of different classes of antibiotics could be related to certain cancer prevalence figures in different European countries. Our results indicated that countries with relatively high consumption of narrow-spectrum penicillin (J01CE, J01CF) and tetracycline (J01A), like certain Scandinavian countries, showed a higher incidence of female colorectal cancer, female lung cancer, melanoma, breast, prostate and uterus corpus cancer. Countries with relatively higher consumption of broad-spectrum penicillin (J01CA, J01CR) and some broad-spectrum antibiotics (J01D, J01F, J01M), like Greece, Hungary, Slovakia, France, etc. showed a higher incidence rate of male lung cancer and male bladder cancer. The higher incidence rate of different cancer types showed association with the higher consumption of antibiotics with "augmenting" properties and with less consumption of antibiotics with "inhibitory" properties.
肠道微生物群改变在恶性肿瘤发生发展中的潜在作用最近在一些出版物中被提及。在外部因素中,抗生素被认为是能够在肠道菌群中导致生态失调的最重要因素,无论是暂时还是永久性的。人类微生物群在维持适当的人类健康方面有多种有益作用,但其改变与许多疾病的发生有关。我们的基本目标是探讨不同类别抗生素的使用与欧洲国家最常见癌症类型(男性、女性)发病率之间的可能关系。我们建立了一个1997 - 2018年平均每年抗生素使用量的数据库,并将使用数据与30个欧洲国家2018年计算的八种最常见癌症发病率进行了比较。皮尔逊相关性分析表明,抗生素使用数据与癌症患病率之间存在不同程度的正(支持性)和负(抑制性)显著关联。据观察,某些具有正相关性的抗生素类别可能会增加某些癌症类型的发病率,而其他具有负相关性的抗生素类别可能会显示出一定的抑制作用。不同类别的抗生素相对较高或较低的使用模式可能与欧洲不同国家的某些癌症患病率数据有关。我们的结果表明,某些斯堪的纳维亚国家等窄谱青霉素(J01CE、J01CF)和四环素(J01A)使用量相对较高的国家,女性结直肠癌、女性肺癌、黑色素瘤、乳腺癌、前列腺癌和子宫体癌的发病率较高。希腊、匈牙利、斯洛伐克、法国等广谱青霉素(J01CA、J01CR)和一些广谱抗生素(J01D、J01F、J01M)使用量相对较高的国家,男性肺癌和男性膀胱癌的发病率较高。不同癌症类型的较高发病率与具有“增强”特性的抗生素较高使用量以及具有“抑制”特性的抗生素较低使用量有关。